CDC7 and cancer: By demonstrating a major role for PP1 in the regulation of Cdc7 activity, our work also has implications for the best use of DDK inhibitors as anti-cancer agents [39,40,68,69], in particular suggesting that modulation of PP1 activity could enhance their therapeutic efficacy.